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Introduction
In 1930, William Chester and pathologist Jakob Erdheim 
discovered the pathology currently known as Erdheim Chester 
disease. There are only approximately 249 histologically confirmed 
patients to have been diagnosed with this disease as noted in the 
medical literature [1]. This rare systemic inflammatory disease 
confuses pathologists, in that there are characteristics which are 
both neoplastic and non-neoplastic in nature. ECD is not classified 
as a cancer, autoimmune disorder, storage disorder, infectious 
disease, or any other clear pathological entity. It is characterized as 
both a Non-Langerhans cell histiocytosis; however, it may coexist 
with Langerhans histiocytosis. Inflammatory infiltrates are noted 
on pathological specimens, radiologically sclerosis of  long bones 
may be noted, as well as involvement of  the jaw in rare cases. 
Radio-nucleotide scans show high metabolic activity in these areas 
of  sclerosis, most notably in the bilateral femurs in most patients. 
The origins of  this disease are unclear, although recently there has 
been genetic analysis which reveals association with chromosomal 
translocation t(12;15;20) (q11;q24;p13.3), and somatic BRAF gene 
mutations. These findings are preliminary in nature, and further 
genetic analysis is needed to better characterize the disease. ECD 
mostly affects middle-aged men with clinical manifestations 
differing with age, but most commonly include: diabetes 
insipidus, neurological and/or constitutional symptoms, and bone 
pain (described as nearly universal in presentation). Neurological 
involvement has been implicated as an independent predictor of  
death in ECD patients, occurring in 51% of  the patients over the 
course of  the disease and in 23% at disease onset. Diagnostic 
critera for this disease process are controversial and ever changing. 
Biopsy demonstrating characteristic histopathologic features in 
addition to clinico-radiographic features, most often sclerosing 
long bone involvement, is required to establish a diagnosis. 
The major criterion is the distinct histological pattern that 
characterizes the condition. Histological findings are sufficient to 
confirm ECD, which includes the presence of  foamy histiocytosis 
with signs of  inflammation Touton-type giant cells. Numerous 
laboratory and radiographic analyses are needed upon diagnosis 
to ascertain the extent of  disease. Mutational analysis establishing 
BRAF and RAS mutational status is needed as well, as these bear 
implications for therapy with BRAF inhibition. Overall results of  
treatment have been generally disappointing as reported in one of  
the largest reviews on the disease by Veyssier-Belot et al., nearly 
60% mortality within a 2.7 years follow up [2]. 
We describe a case report of  an indolent form of  Erdheim 
Chester Disease (ECD), in a patient in whom the disease has been 
present for approximately 14 years. Despite widespread sclerosis 
of  long bones in the extremities, the patient has no complaints of  
peripheral bone pain. Although, the patient does have involvement 
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of  the jaw with subsequent loss of  multiple teeth secondary to the 
facial manifestations of  the disease. This is also the first patient 
have the disease incidentally discovered after an ACL injury, and 
the first ECD patient to receive an ACL reconstruction.
Case Report
Patient SF at the time of  initial presentation was a 54 year old 
female, presenting to her family practice physician secondary to 
knee pain. She incurred a “knee sprain” while on vacation the 
week prior. Upon plain film imaging performed in the primary 
care provider’s office, marked boney sclerosis was noted. The 
patient was referred to an orthopedic surgeon for further 
evaluation. Orthopedic evaluation revealed a ruptured ACL, and 
the boney sclerosis was worrisome for an underlying pathological 
state. After appropriate radiological and laboratory workup by the 
orthopedic physician, she was referred to an oncologist for further 
evaluation. MRI imaging in combination with laboratory findings 
pointed toward myeloma. During the ACL Reconstruction, a 
boney biopsy was taken and subsequent biopsies in the future 
eventually revealed Erdheim Chester Disease. Immunochemistry 
noted positive for CD68, CD1a and S100 markers. The histology 
was characteristic of  EDC, as explained previously. The histology 
differed from that of  acute tendon injury. This typically includes 
fibroblasts surrounded by a collagen extracellular matrix, elastin, 
mucopolysaccharides, glycoproteins, and acute inflammatory 
cells. The patient over the course of  14 years has developed jaw 
pain and biopsies of  the region revealed EDC in this region as 
well. The effects on the jaw have led to the loss of  numerous teeth 
and jaw pain. The patient eventually developed acute renal failure, 
and exophthalmos, for which she underwent a decompressive 
procedure by an ophthalmologist. She is currently taking 
combinations of  mediations to treat the EDC, which includes 
interferon therapy.
Discussion
The patient initially presented to physicians with pain at the knee 
secondary to a “sprain” she incurred while on vacation, which 
subsequently was diagnosed as an ACL rupture. This is the first 
case to present in this manner. Most patients present with a 
combination of  bone pain, diabetes, and neurological symptoms, 
of  which this patient had none. The patient underwent ACL 
reconstruction with bone-patellar-bone allograft without any 
complications. In a previous case report describing bilateral total 
knee arthroplasty in a patient with ECD, the patient was noted to 
have severe villous synovitis, as well as bone which was so dense/
sclerotic; “Because of  the massive osteosclerosis of  the trabecular 
bone and obliteration of  the marrow space, it was necessary to 
place the intramedullary alignment guide ….for the distal cut of  
the femur in the correct position by drilling the femoral canal 
under fluoroscopic control. …..the osseous cuts required three 
saw blades for each cut as a result of  the osteosclerosis of  the 
distal part of  the femur and proximal part of  the tibia. Following 
ligament balancing of  the extension gap, the final cuts of  the 
femur with the saw guide required two additional saw blades” [3]. 
Although sclerosis was noted on pre-operative imaging, the bone 
was not so dense as to cause deviations in surgical procedure as 
seen in the case report of  the total knee arthroplasty case. In fact, 
the ACL reconstruction occurred as normal performed, and there 
were no obvious signs of  inflammatory changes intra-articularly 
as noted in the total knee case report with villous synovitis. It 
was previously speculated that severe synovitis and inflammatory 
markers intra-articularly could contribute the progression of  
cartilage destruction and joint disease as seen in previous case 
reports. The patient in this case report displayed nearly pristine 
joint space, with no obvious signs of  synovitis or joint destruction 
(see Image 2). This paperdispels previous speculations ECD 
could have contributed to the synovitis, overall inflammatory 
environment in the knee, and overall joint destruction.
Image 1. This displays the Initial Plain film imaging of  the effected left lower extremity, displaying marked boney sclerosis 
commonly seed with EDC. AP and Lateral of  the effected femur are noted in these images.
 
Image 2. Arthroscopic images of  the left knee at time of  ACL reconstruction. No overt signs of  joint destruction or inflam-
matory changes are noted in is arthroscopic evaluation.
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The sclerotic boney nature of  the disease may lead to changes 
in how the ligamentous attachments of  the bone absorb and 
transmit stress from the joint, secondary to abnormal interactions 
at the bone-ligament interface. We propose the idea that these 
sclerotic bones changes may predispose patients to ligamentous 
injuries as noted in this patient. Severe villous synovitis at the knee 
has been noted in patients with EDC by orthopedic surgeons in 
the past. Although no overt inflammatory changes were seen 
intra-articularly with the patient in question, microscopic changes 
may have been evident in the ligamentous structure of  the ACL, 
which may have in itself  lowered the threshold for incurring an 
injury. Although, these are both novel idea and more research is 
needed in the field to verify such speculations.
This case may represent an indolent form of  the disease not 
previously revealed. Previous studies within the past 4-5 years 
have begun to investigate genetic linkages to the disease, but the 
genetic linkage is not clear. The patient in this case report has 
experienced renal disease and neurological symptoms (in the form 
of  exophthalmos), but lacks many most common presentations 
seen in the disease (as previously described). She also has survived 
over 14 years with the pathology, with a disease mortality of  
around 60% in less than 3 years. Despite the independent risk 
factor of  neurological symptoms as a risk factor for death, this 
patient continues to preserver. This is the 8th case in the medical 
literature to describe a patient with jaw involvement in the setting 
of  ECD [4-10]. The addition of  this rare entity of  the disease, in 
combination with rare presentation as described thus far, makes 
this an exceedingly rare presentation. We propose the idea of  
variations in the genetic mutations, and call for more research to 
be done into the field to better diagnose patients and give them 
prognostic outlook on their condition.
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